Product Overview IGF-1 LR3 is a synthetic peptide research compound widely studied in controlled laboratory environments focused on growth factor signalling pathways, receptor interactions and cellular communication mechanisms
Pre-existing cardiac, kidney, liver, or splenic conditions
The dosage typically ranges from 300 to 400 micrograms per day (totaling 6 to 8 units, divided between morning and evening), considering that one unit corresponds to 50mcg
Respected by researchers and physicians alike, it is known for promoting healthier cholesterol levels, supporting weight management, and maintaining healthy blood pressure
Sale and distribution of such peptides is unlawful unless conducted within an authorized research context. FDA, Peptide and Protein Drug Products: CMC Regulatory Expectations IGF-1 LR3 is also prohibited by WADA and competitive athletic organizations